RxSight, Inc.
RXST
$25.84
$0.622.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.46M | -30.69M | -36.77M | -44.50M | -48.61M |
| Total Depreciation and Amortization | 3.62M | 4.19M | 4.17M | 4.38M | 4.24M |
| Total Amortization of Deferred Charges | -- | 0.00 | 4.00K | 146.00K | 287.00K |
| Total Other Non-Cash Items | 16.10M | 14.37M | 14.27M | 12.81M | 11.56M |
| Change in Net Operating Assets | -9.21M | -8.85M | -11.30M | -5.98M | -9.07M |
| Cash from Operations | -16.95M | -20.99M | -29.62M | -33.14M | -41.59M |
| Capital Expenditure | -5.44M | -6.18M | -5.73M | -6.03M | -4.81M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -93.87M | -89.88M | -63.80M | 56.54M | -17.32M |
| Cash from Investing | -99.31M | -96.07M | -69.53M | 50.51M | -22.13M |
| Total Debt Issued | -- | 0.00 | 0.00 | 20.00M | 20.00M |
| Total Debt Repaid | -61.00K | -83.00K | -20.11M | -60.14M | -60.15M |
| Issuance of Common Stock | 128.92M | 129.51M | 139.61M | 50.20M | 105.96M |
| Repurchase of Common Stock | -4.77M | -4.77M | -3.22M | -3.22M | -1.42M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -768.00K | -754.00K | -1.49M | -2.63M | -2.86M |
| Cash from Financing | 123.32M | 123.91M | 114.79M | 4.21M | 61.52M |
| Foreign Exchange rate Adjustments | -9.00K | 11.00K | -1.00K | 1.00K | 6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -1.00K | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 7.05M | 6.86M | 15.64M | 21.58M | -2.19M |
